港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

531.734

-1.100-0.21%

漲家數：10

跌家數：23

平家數：- -

市盈率：- -

高：543.539

開：532.796

低：528.924

收：532.848

成交量：7,286.25萬

成交額：17.67億

市值：3,395.27億

流通市值：3,026.01億

資料載入中...

總覽新聞資訊

八月新基供給走弱醫藥板塊獲逆向佈局

《盈警》微創心通(02160.HK)預計中期虧損不多於2,500萬美元

阿斯达克财经

心通醫療-B(02160.HK)盈警：預計中期淨虧損不高於2500萬美元

微創心通-B(02160.HK)發盈警預計中期淨虧損不高於2500萬美元

微創心通-B：預計2026年上半年營收不低於1.53億美元，淨虧損不超過2500萬美元

再鼎醫藥(09688)授出購股權及受限制股份單位

8月，真正的機會在這個方向！

A股公告精選 | 5倍大牛股緊急澄清傳聞 6連板醫藥龍頭提示風險

智通财经网

楊德龍：科技「六大賽道」有望輪番表現關注細分行業龍頭機會

中期業績亮眼、調研熱度攀升……醫藥板塊燃爆了！機構看好三條主線

金融投资网

利空來襲！A股震盪分化影視股延續強勢醫藥股繼續活躍

东方财富网

啓明醫療－Ｂ(02500)股價上升6.019%，現價港幣$1.145

阿斯达克财经

港股異動 | 劑泰科技-P(07666)再升逾7% 8月初至今累漲近三成已連續多日領升AI製藥板塊

港股午評|恒生指數早盤跌0.63% CRO概念繼續走高

《輪動華泰》國際油價大幅反彈創新醫藥股份續獲熱炒

阿斯达克财经

A股午盤 | 指數分化創指漲1.41%，MLCC、醫藥板塊領升

半年報驗證創新藥景氣預期！T+0恒生創新藥ETF華泰柏瑞（520500）聚焦產業鏈復甦機遇

港股異動 | 康寧傑瑞製藥-B(09966.HK)再升逾4% 與Pathos達成海外授權許可協議核心資產實現出海

億騰嘉和(06998)股價上升5.507%，現價港幣$1.82

阿斯达克财经

開拓藥業-B再漲近9% 附屬與上海康美就KT-939簽訂戰略合作框架協議

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1574/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":531.7478,"timestamp":1786519401218,"preClose":532.84753,"halted":0,"volume":72879101,"delay":0,"changeRate":-0.002064,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-1.099731,"latestTime":"08-12 15:23:22","open":532.796,"high":543.53937,"low":528.924,"amount":1767117626,"amplitude":0.027429,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1786522200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1786498200000,1786507200000],[1786510800000,1786521600000]],"pbRate":4.320612,"peRate":-81.172646,"turnoverRate":0.002645,"increases":11,"decrements":22,"flats":0,"marketCap":339526985008,"floatMarketCap":302600672208},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":543.53937,"amplitude":0.027429,"preClose":532.84753,"low":528.924,"pbRate":"4.320612","latestPrice":531.7335,"volume":72862501,"delay":0,"open":532.796,"prevYearClose":556.26263,"prevWeekClose":516.343,"prevMonthClose":473.313,"prevQuarterClose":453.519,"fiveDayClose":485.719,"twentyDayClose":525.18,"sixtyDayClose":579.587,"secType":"PLATE","market":"HK","turnoverRate":0.002645,"peRate":-81.172646,"marketCap":339518705968,"floatMarketCap":302592393168,"timestamp":1786519398048,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":10,"down":23,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658413249","title":"八月新基供給走弱 醫藥板塊獲逆向佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2658413249","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658413249?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 02:36","pubTimestamp":1786473360,"startTime":"0","endTime":"0","summary":"从行业特征来看，多家公募以行业主题发起式基金对细分赛道进行快速布局，其中，调整充分、估值处于低位的医药板块获得重点关注。公募机构借助发起式基金的低门槛优势，加速布局前期调整充分、估值回归合理区间的赛道，其中医药板块因调整时间较长、基本面韧性突出，已成为逆向投资的重点方向。截至目前，多只创新药ETF自年内低点反弹逾20%，合计吸金超百亿元；此外，还有部分医药主题主动权益基金最高涨幅超30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-12/doc-inimysyf4300731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","159938","BK1515","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658914649","title":"《盈警》微創心通(02160.HK)預計中期虧損不多於2,500萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658914649","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658914649?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 00:12","pubTimestamp":1786464720,"startTime":"0","endTime":"0","summary":"微创心通－Ｂ(02160.HK) 发盈警，预计6月止六个月录得净亏损不高于2,500万美元，收入不低于1.53亿美元。期间，由于完成收购心律管理业务而首次全部合并入集团财务报表。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-08-11 16:25。)过往派息公布日期派息事项派息内容2026/03/30末期业绩无派息2026/01/22特别业绩合并：5股合并为1股2025/08/28中期业绩无派息2025/03/27末期业绩无派息AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220906143939119_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220906143939119_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1537688/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1537688/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02160","BK1574","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658725911","title":"心通醫療-B(02160.HK)盈警：預計中期淨虧損不高於2500萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658725911","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658725911?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 23:37","pubTimestamp":1786462627,"startTime":"0","endTime":"0","summary":"格隆汇8月11日丨心通医疗-B公告，由于集团于2025年12月19日完成收购心律管理业务，心律管理业务于截至2026年6月30日止六个月首次全部合并入集团财务报表。根据对集团报告期未经审核综合管理账目的初步审阅及对董事会目前可得最新资料的评估，集团预期报告期录得收入不低于1.53亿美元，录得净亏损不高于2500万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260811/32332168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1583","BK1100","BK1574","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658291642","title":"微創心通-B(02160.HK)發盈警 預計中期淨虧損不高於2500萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658291642","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658291642?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 22:15","pubTimestamp":1786457756,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1239","BK1100","02918","BK1574","02160","BK1225","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131236442","title":"微創心通-B：預計2026年上半年營收不低於1.53億美元，淨虧損不超過2500萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1131236442","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131236442?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 22:14","pubTimestamp":1786457649,"startTime":"0","endTime":"0","summary":"微创心通-B（02160.HK）发布了业绩展望：公司预计2026年上半年营收将至少达到1.53亿美元；与此同时，期间净亏损则有望控制在不超过2500万美元的水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","BK1574","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658915078","title":"再鼎醫藥(09688)授出購股權及受限制股份單位","url":"https://stock-news.laohu8.com/highlight/detail?id=2658915078","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658915078?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 21:56","pubTimestamp":1786456598,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，本公司于授出日期根据2024年股权激励计划授出1000份(以美国存托股份计)购股权、2600股(以美国存托股份计)受限制股份单位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4548","BK4588","09688","ZLAB","BK4139","BK1161","BK1574","BK4585","LU2488822045.USD","BK1588","BK4531","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658028918","title":"8月，真正的機會在這個方向！","url":"https://stock-news.laohu8.com/highlight/detail?id=2658028918","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658028918?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 20:50","pubTimestamp":1786452609,"startTime":"0","endTime":"0","summary":"眼下的市场，一半火焰，一半海水。短期反弹还是会转化为中长期的反转，是当前的一个核心重点，科技股止跌，但内部分化加剧。创新药等非AI科技则纷纷启动新一轮上涨，但整体增量资金入场积极性较弱，市场又到了关键的窗口期。　　主力资金在科技股与非科技之间加快轮动，这在今天的市场再一次鲜明体现。硬科技中的太极实业、洁美科技等均强势涨停，创新药中的甘李药业、药康生物等均创出新高。8月接下来真正的机会到底在哪里？","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/11/20260811164641.jpeg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/11/20260811164641.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangjuejin/20260811/32332076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1147","09834","XLK","IBBQ","BK4588","02834","LNGR","07261","03034","MEDX","03455","BK1574","TTTN","BK4585","BK1161","07568","07266","03086","09086","07522","06978","VGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990418","title":"A股公告精選 | 5倍大牛股緊急澄清傳聞 6連板醫藥龍頭提示風險","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990418","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990418?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 20:15","pubTimestamp":1786450506,"startTime":"0","endTime":"0","summary":"工业富联公告称，2026年上半年营业收入5578.61亿元，同比增长54.63%。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260811/20260811200223_20171.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260811/20260811200223_20171.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478644.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1515","BK1161","399300","159982","BK1574","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658399355","title":"楊德龍：科技「六大賽道」有望輪番表現 關注細分行業龍頭機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2658399355","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658399355?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 16:23","pubTimestamp":1786436580,"startTime":"0","endTime":"0","summary":"去年年初我就提出科技“六大赛道”的观点。现在来看，这六大赛道轮番表现，成为AI时代真正受益的方向，包括芯片半导体、算力算法、人形机器人、商业航天、固态电池、生物医药等。建议大家把握住板块轮动，配置行业龙头股，抓住机会。我已经给大家指明，科技行情没有结束，并给大家提出了六大赛道；现在是行业轮动，大家可以在这六大赛道里面寻找龙头股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjsy/2026-08-11/doc-inimxrnm7544791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","PBOT","ROBT","BK4585","BK4588","IBBQ","06978","VGT","ARTY","RTOO","BK1574","WDRN","MEDX","IQM","UBOT","BK1161","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658993509","title":"中期業績亮眼、調研熱度攀升……醫藥板塊燃爆了！機構看好三條主線","url":"https://stock-news.laohu8.com/highlight/detail?id=2658993509","media":"金融投资网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658993509?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 16:10","pubTimestamp":1786435855,"startTime":"0","endTime":"0","summary":"金融投资网记者张璐璇近期，A股医药板块表现亮眼。上周，A股生物医药指数上涨6.27%，显著超越同期沪深300指数涨幅；本周以来，创新药、CXO概念股继续冲高。多家机构认为，进入8月中报披露期，创新药商业化进展成为市场核心主线之一。“2026年中报季有望成为验证商业化逻辑、重塑板块估值的重要窗口。龙头股打头阵已定调，行业整体表现值得期待。”东吴证券研究所指出。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608113837886120.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608113837886120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159938","BK1515","BK1161","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658599554","title":"利空來襲！A股震盪分化 影視股延續強勢 醫藥股繼續活躍","url":"https://stock-news.laohu8.com/highlight/detail?id=2658599554","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658599554?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 16:10","pubTimestamp":1786435800,"startTime":"0","endTime":"0","summary":"今天的市场，真的是跌宕起伏：上午低开，随后拉升；午后突然跳水。一起找找原因吧。8月11日，市场全天震荡分化，三大指数涨跌互现。截至收盘，沪指跌0.82%，深成指跌0.4%，创业板指涨0.34%。两市共1615只个股上涨，60只个股涨停，3777只个股下跌。影视股延续强势，北京文化2连板，华智数媒20cm涨停。医药股继续活跃，百花医药6连板，哈药股份等涨停。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11791,202608113837875117.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11791,202608113837875117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["09939","399300","159982","BK1574","159938","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658460964","title":"啓明醫療－Ｂ(02500)股價上升6.019%，現價港幣$1.145","url":"https://stock-news.laohu8.com/highlight/detail?id=2658460964","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658460964?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 13:21","pubTimestamp":1786425660,"startTime":"0","endTime":"0","summary":"[上升股]启明医疗－Ｂ(02500) 股价在下午01:21比前收市价上升6.019%，现股价为港币$1.145。至目前为止，今日最高价为$1.145，而最低价为$1.08。总成交量为10.95万股，总成交金额为港币$12.221万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608111860/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608111860/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1574","BK1100","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658154961","title":"港股異動 | 劑泰科技-P(07666)再升逾7% 8月初至今累漲近三成 已連續多日領升AI製藥板塊","url":"https://stock-news.laohu8.com/highlight/detail?id=2658154961","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658154961?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 12:59","pubTimestamp":1786424368,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P近期持续获资金追捧，连续多日领涨AI制药板块，8月初至今累计涨幅已接近三成。截至发稿，涨6.25%，报12.75港元，成交额1738.22万港元。消息面上，恒生指数公司或于2026年8月25日公布半年度指数调整结果，所有变动将于9月4日收市后实施并于9月7日起生效。国海医药团队预计，剂泰科技即将入通。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1161","ARTY","CHAT","QTOC","01477","AGIX","BK1191","VTHR","BK1574","VXUS","07666","KCAI","BK4588","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969219","title":"港股午評|恒生指數早盤跌0.63%    CRO概念繼續走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969219","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969219?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 12:00","pubTimestamp":1786420834,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数跌0.63%，跌163点，报25773点；恒生科技指数跌1.27%。港股早盘成交1158亿港元。药明康德司法取得进展，有利于CXO公司在海外争取新的订单。再鼎医药涨超5%，Q2产品收入环比增长11%，花旗看好中国业务下半年企稳。津上机床中国涨超5%，电子与AI液冷两大领域在新订单占比约四成。黄金股普遍承压。油价走高加剧通胀上行担忧，美联储鹰派释放强硬信号。中国黄金国际跌2.5%；紫金矿业跌3.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02899","LU0287142896.SGD","LU0868486357.SGD","83115","LU0266512473.USD","LU0049853897.USD","02631","07500","09067","BK1190","LU0348766576.USD","LU1719994722.HKD","LU0886674414.USD","LU1251922891.USD","LU0164880469.USD","LU2399975544.HKD","03759","LU0979878070.USD","06951","BK1544","LU0048580855.USD","LU0307460666.USD","002821","LU0043850808.USD","LU0164939612.USD","LU0918141887.USD","LU0821914370.USD","LU1064131342.USD","SG9999001093.SGD","LU1105468828.SGD","LU2177674079.SGD","LU2039709279.SGD","300759","LU0061477393.USD","07300","LU0345780281.USD","LU0274383008.USD","BK1583","BK1198","LU1808992512.USD","LU0620787316.HKD","BK1183","LU1769817179.HKD","BK1129","02493","LU1224709979.USD","LU0540923850.HKD","03423","LU0345780521.USD","LU0737861772.HKD","02800","LU0417516902.SGD","LU1481107354.HKD","LU2488822045.USD","BK1505","LU0082770016.SGD","LU0348814723.USD","LU0329678337.USD","LU0096374516.USD","LU2097828714.EUR","03037","IE0032431581.USD","LU0456854461.SGD","LU0797268264.HKD","LU1188198961.HKD","LU0140636845.USD","09088","LU0417516738.SGD","LU1242518857.USD","PONY","ZLAB","601899","LU3063872942.SGD","LU0244354667.USD","BK1141","LU2097828557.USD","LU2226246903.HKD","09688","09115","LU0149721374.USD","BK1574","01651","02026","LU0572944931.SGD","LU1282648689.USD","LU0326950275.SGD","LU1770034418.SGD","BK1587","03032","02833","LU0588546209.SGD","HK0000306685.HKD","LU1794554557.SGD","LU0348827113.USD","06616","BK1170","HK0000320264.USD","LU2008162690.USD","LU2097828474.EUR","BK1576","LU1831875114.USD","LU0463099449.HKD","LU0918141705.HKD","LU0039217434.USD","LU0278937759.USD","LU0348767384.USD","LU0165289439.USD","LU1504937902.USD","LU0106959298.USD","ZIJMY","LU0329678170.USD","07200","LU0327786744.USD","JINFF","LU0431992006.USD","LU0737861699.HKD","LU0370786039.SGD","LU1303224171.USD","LU2097828805.USD","SG9999003461.SGD","LU0348825331.USD","LU1048596156.SGD","LU1961090484.USD","LU1988902786.USD","BK1588","688062","01548","LU0634319403.HKD","LU2264538146.SGD","82800","MCHmain","LU0173614495.USD","07226","LU0561508036.HKD","03033","LU0228659784.USD","01541","BK1594","LU0348735423.USD","SG9999002463.SGD","LU0469268626.HKD","LU0871576103.HKD","BK1161","LU1720050803.USD","SG9999004220.SGD","BK1169","06821","03419","LU1769817096.USD","HK0000320223.HKD","BK1592","LU0266512127.USD","HSI","LU0828237940.HKD","688234","03088","HK0000306701.USD","BK1191","03115","LU0181495838.USD","LU0269904917.USD","02837","LU0211977185.USD","LU0828238088.HKD","HSTECH","03417","LU2460026573.USD","LU0106252389.USD","LU0509642566.USD","513600","LU1242518931.SGD","LU2097828631.EUR","07552","LU0164865239.USD","LU0828237510.HKD","02099","LU0082770016.USD","LU0328353924.USD","03067","LU0531971595.HKD","BK1109","LU0348816934.USD","300408","HHImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969260","title":"《輪動華泰》國際油價大幅反彈  創新醫藥股份續獲熱炒","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969260","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969260?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:55","pubTimestamp":1786420500,"startTime":"0","endTime":"0","summary":"------ 华泰国际轮证是日焦点 ------国际油价大幅反弹 “三桶油”造好港股创新医药股份续获热炒 药明系月内升逾两成------------------------------------------------------------------------美伊谈判迟迟未有进展，而双方互相要求赔偿军事冲突损失，国际油价单日飙升5%，隔夜美股普遍承压，三大股指小幅收跌，半导体股份则跌幅靠前。若发行人无力偿债或违反其责任，投资者可能无法收回部分甚或全部应收款项。结构性产品价格可升亦可跌，持有人可能会损失全部投资。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250808181954789_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250808181954789_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1537575/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1537575/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1574","159938","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969906","title":"A股午盤 | 指數分化創指漲1.41%，MLCC、醫藥板塊領升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969906","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969906?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:45","pubTimestamp":1786419925,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月11日，A股三大指数集体低开后走势分化，创业板指低开高走涨超1%，沪指则围绕平盘线窄幅震荡。截至午间收盘，沪指跌0.05%，深成指涨0.65%，创业板指涨1.41%。科创50小幅上涨0.16%，北证50微跌0.10%。此外，三星电机已于8月1日起对MLCC产品全线涨价30%，太阳诱电宣布自9月1日起跟进涨价，全球MLCC正进入新一轮景气周期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478381.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","09939","159938","BK1515","399300","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969144","title":"半年報驗證創新藥景氣預期！T+0恒生創新藥ETF華泰柏瑞（520500）聚焦產業鏈復甦機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969144","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969144?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:40","pubTimestamp":1786419600,"startTime":"0","endTime":"0","summary":"支持场内T+0的恒生创新药ETF华泰柏瑞7月以来日均成交额达23.4亿元，相较2026年上半年8.81亿元的日均成交额，资金活跃度显著攀升。交投踊跃之下，恒生创新药ETF华泰柏瑞截至8月10日最新份额、规模分别达22.12亿份、32.19亿元，今年以来产品份额增加76.68%，规模增加66.1%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-08-11/doc-inimxewr7636555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1161","IBBQ","520500","159992","MEDX","LNGR","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969303","title":"港股異動 | 康寧傑瑞製藥-B(09966.HK)再升逾4% 與Pathos達成海外授權許可協議 核心資產實現出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969303","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969303?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:33","pubTimestamp":1786419186,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969145","title":"億騰嘉和(06998)股價上升5.507%，現價港幣$1.82","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969145","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969145?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:33","pubTimestamp":1786419180,"startTime":"0","endTime":"0","summary":"[上升股]亿腾嘉和(06998) 股价在上午11:33比前收市价上升5.507%，现股价为港币$1.82。至目前为止，今日最高价为$1.82，而最低价为$1.685。总成交量为65.4万股，总成交金额为港币$113.678万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608111531/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608111531/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1583","BK1161","06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658966047","title":"開拓藥業-B再漲近9% 附屬與上海康美就KT-939簽訂戰略合作框架協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2658966047","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658966047?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:19","pubTimestamp":1786418381,"startTime":"0","endTime":"0","summary":"消息面上，8月5日，开拓药业附属公司苏州开拓与丽宝康美旗下上海康美建立战略合作关系，围绕功效性原料KT-939在化妆品领域的应用转化、配方研发、工艺验证及 ODM/OEM 生产制造等方向开展协同合作，共同推动相关创新成果在化妆品领域的规范化应用与产业化转化。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478366.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","SG9999004220.SGD","VXUS","BK4585","LU0541501648.USD","BK1161","BK4115","LU0541502299.USD","KCAI","BK1574","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":2,"totalSize":328,"code":"91000000","status":"200"}]}}